Last updated 11 days ago

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

30 patients around the world
Available in Spain, Brazil, Argentina, Mexico, United States
Alexion Pharmaceuticals, Inc.
30Patients around the world
This study is for people with
Hypophosphatasia
Requirements for the patient
To 11 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy